Key result
Chemical crosslinking and mass spectrometry confirm double hairpin belt model as human APOA2 primary structure.
Why the study?
Apolipoprotein A-II's structural configuration and interactions in lipid-bound human HDL were not fully characterized.
The development of a double hairpin belt structural model for human APOA2 on HDL provides a molecular basis for understanding its role in HDL maturation and reverse cholesterol transport.
Does not guide HDL therapies; leaves open functional validation of APOA2 structure in human reverse cholesterol transport.
Apolipoprotein A-II, the second most abundant protein in HDL, plays a key role in HDL maturation and reverse cholesterol transport. It has a stronger affinity for lipids than apolipoprotein A-I (APOA1), which forms HDL's structural scaffold. Like APOA1, APOA2 mainly consists of amphipathic alpha helices that help it interact with lipid surfaces. Using computer modeling and mutagenesis, we developed a structural model for lipid-bound human APOA2. The protein's single disulfide bond restricts it to a belt-like configuration in discoidal HDL particles. Our model shows several key features: (i) most basic residues of APOA2 are in the hairpin loop; (ii) salt bridges and π-π interactions stabilize the structure; (iii) two high-lipid affinity helical regions are in each APOA2 monomer; and (iv) the hairpin structure facilitates interactions with other proteins like APOA1 or APOA2. Chemical crosslinking and MS/MS analysis identified 16 crosslinks; Fifteen of the 16 crosslinks are consistent with the double hairpin belt model, strongly supporting the proposal that the disulfide-dimer double hairpin belt is the primary structure of APOA2 in humans.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question. Chemical cross-linking and computational modeling was evaluated on Structural conformation of APOA2. Chemical crosslinking and MS/MS analysis identified 16 crosslinks, 15 of which are consistent with the double hairpin belt model, supporting it as the primary structure of APOA2 in humans.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: